hypertension
Conditions
Interventions
Control group
Telemonitoring group
Telemedicine group
Sponsors
Tokyo Women's Medical University Department of Internal Medicine II, Endocrinology and Hypertension
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Uncontrolled hypertension (home blood pressure >= 135/85 mmHg) Untreated or antihyperntensive medication unchanged for >= 4 weeks Capable of measuring blood pressure at home Owns and capable of using smartphone or equivalent device Able to give written informed consent
Exclusion criteria
Exclusion criteria: Unable to measure home blood pressure Pregnant women and those expecting to become pregnant Cardiovascular events within 6 months History of coma due to hyper or hypoglycemia Type 1 diabetes with inadequate glycemic control Diabetic patients on insulin Chronic kidney disease with eGFR < 30 mL/min/1.73m2 Secondary hypertension excluding non-operative primary aldosteronism Sleep apnea with indication for positive airway pressure treatment Atrial fibrillation Scheduled for operation or intervention Psychiatric conditions including alcoholism and substance abuse Serious medical condition Subject of other clinical trial Judged unfit by the investigators
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| time-to-control of blood pressure | — |
Secondary
| Measure | Time frame |
|---|---|
| Rate of blood pressure control, quality of life (EQ-5D), adherence (Morisky score), types and amounts of antihypertensive medication, medical costs, major adverse cardiovascular events, indices of atherosclerosis, serum creatinine, urinary protein, adverse events. | — |
Countries
Japan
Contacts
Public ContactJunichi Yatabe
Tokyo Women's Medical University Department of Internal Medicine II, Endocrinology and Hypertension
Outcome results
None listed